{"transactions":[{"id":700050,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-31T20:10:11.000Z","date":"2026-07-29","kind":"purchase","planned":false,"acquired":true,"shares":23210,"price":2.585,"value":59997.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement under a Securities Purchase Agreement dated July 29, 2026 (\"SPA\"), which purchase is exempt from the registration requirements of Section 5 of the Securities Exchange Act of 1934, as amended, pursuant to Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D thereunder. Additionally, the reporting person is entitled to receive common warrants exercisable for an aggregate of up to 23,210 shares of common stock. Under the terms of the SPA, issuance of the common warrants is subject to stockholder approval under Nasdaq Listing Rule 5635(d). Upon issuance, the common warrants will be exercisable immediately and expire 5.5 years from date of issuance."}],"balance_after":125845,"source":{"system":"sec-edgar","filing":"0001493152-26-035634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000149315226035634/ownership.xml","form_type":"4"}},{"id":762042,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2026-05-27T23:26:32.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":113879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":118110,"derivative":{"exercise_price":1.28,"exercise_date":"2026-05-22","expiration_date":"2031-11-22","underlying":"Common Stock","underlying_shares":113879},"source":{"system":"sec-edgar","filing":"0001493152-26-025478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000149315226025478/ownership.xml","form_type":"4"}},{"id":762041,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-27T23:26:32.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":113879,"price":1.405,"value":159999.995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which purchase is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":615790,"source":{"system":"sec-edgar","filing":"0001493152-26-025478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000149315226025478/ownership.xml","form_type":"4"}},{"id":1140596,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-20T20:35:35.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":8054,"price":7.45,"value":60002.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes.  The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering.  The Notes converted after the closing of the Company's registered offering on May 15, 2025.  The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":501911,"source":{"system":"sec-edgar","filing":"0000950170-25-075259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000095017025075259/ownership.xml","form_type":"4"}},{"id":1153875,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2025-05-09T21:32:37.000Z","date":"2025-05-07","kind":"purchase","planned":false,"acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":46250,"derivative":{"exercise_price":26,"exercise_date":"2025-05-07","expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":46250},"source":{"system":"sec-edgar","filing":"0000950170-25-068292","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000095017025068292/ownership.xml","form_type":"4"}},{"id":1153874,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-09T21:32:37.000Z","date":"2025-05-08","kind":"purchase","planned":false,"acquired":true,"shares":92500,"price":26,"value":2405000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025,  along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company."}],"balance_after":493857,"source":{"system":"sec-edgar","filing":"0000950170-25-068292","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000095017025068292/ownership.xml","form_type":"4"}},{"id":1625667,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-22T19:24:41.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":739288,"price":1.4,"value":1035003.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended."}],"balance_after":16054156,"source":{"system":"sec-edgar","filing":"0001209191-24-003787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919124003787/doc4.xml","form_type":"4"}},{"id":1779061,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-18T20:36:51.000Z","date":"2023-09-14","kind":"purchase","planned":false,"acquired":true,"shares":1800,"price":2.0782,"value":3740.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.0536 to $2.1109. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15314868,"source":{"system":"sec-edgar","filing":"0001209191-23-049774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919123049774/doc4.xml","form_type":"4"}},{"id":1870296,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-03T00:25:00.000Z","date":"2023-06-02","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":1.5353,"value":1228.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $1.5045 to $1.5666. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15313068,"source":{"system":"sec-edgar","filing":"0001209191-23-034098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919123034098/doc4.xml","form_type":"4"}},{"id":1870295,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-03T00:25:00.000Z","date":"2023-06-01","kind":"purchase","planned":false,"acquired":true,"shares":800,"price":1.6178,"value":1294.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.60 to $1.6311. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15312268,"source":{"system":"sec-edgar","filing":"0001209191-23-034098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919123034098/doc4.xml","form_type":"4"}},{"id":1872223,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T21:47:13.000Z","date":"2023-05-31","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.546,"value":3092.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $1.5148 to $1.5675. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15311468,"source":{"system":"sec-edgar","filing":"0001209191-23-033397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919123033397/doc4.xml","form_type":"4"}},{"id":1872222,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T21:47:13.000Z","date":"2023-05-30","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":1.5527,"value":4658.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $1.4944 to $1.6403. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15309468,"source":{"system":"sec-edgar","filing":"0001209191-23-033397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919123033397/doc4.xml","form_type":"4"}},{"id":2161386,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-12T19:05:08.000Z","date":"2022-09-09","kind":"purchase","acquired":true,"shares":6000,"price":2.7,"value":16200.0,"ownership":{"direct":true},"balance_after":15306468,"source":{"system":"sec-edgar","filing":"0001209191-22-049469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122049469/doc4.xml","form_type":"4"}},{"id":2161385,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-12T19:05:08.000Z","date":"2022-09-08","kind":"purchase","acquired":true,"shares":4000,"price":2.67,"value":10680.0,"ownership":{"direct":true},"balance_after":15300468,"source":{"system":"sec-edgar","filing":"0001209191-22-049469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122049469/doc4.xml","form_type":"4"}},{"id":2164287,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-07T21:45:13.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":6000,"price":2.58,"value":15480.0,"ownership":{"direct":true},"balance_after":15296468,"source":{"system":"sec-edgar","filing":"0001209191-22-049055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122049055/doc4.xml","form_type":"4"}},{"id":2164286,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-07T21:45:13.000Z","date":"2022-09-02","kind":"purchase","acquired":true,"shares":4000,"price":2.55,"value":10200.0,"ownership":{"direct":true},"balance_after":15290468,"source":{"system":"sec-edgar","filing":"0001209191-22-049055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122049055/doc4.xml","form_type":"4"}},{"id":2234361,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-13T21:16:28.000Z","date":"2022-06-10","kind":"purchase","acquired":true,"shares":1520,"price":2.188,"value":3325.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.115 to $2.2301. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15286468,"source":{"system":"sec-edgar","filing":"0001209191-22-036395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122036395/doc4.xml","form_type":"4"}},{"id":2238013,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-09T21:59:45.000Z","date":"2022-06-09","kind":"purchase","acquired":true,"shares":2000,"price":2.245,"value":4490.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.24 to $2.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15284948,"source":{"system":"sec-edgar","filing":"0001209191-22-035554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122035554/doc4.xml","form_type":"4"}},{"id":2238012,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-09T21:59:45.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":1000,"price":2.31,"value":2310.0,"ownership":{"direct":true},"balance_after":15282948,"source":{"system":"sec-edgar","filing":"0001209191-22-035554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919122035554/doc4.xml","form_type":"4"}},{"id":2546528,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-07T23:18:44.000Z","date":"2021-08-31","kind":"purchase","acquired":true,"shares":5830,"price":3.94,"value":22970.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $3.91 to $3.97. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15281948,"source":{"system":"sec-edgar","filing":"0001209191-21-059989","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121059989/doc4a.xml","form_type":"4/A","original_submission_date":"2021-09-02"}},{"id":2546529,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-07T23:17:50.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":8000,"price":3.7625,"value":30100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $3.74 to $3.83. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15270118,"source":{"system":"sec-edgar","filing":"0001209191-21-059988","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121059988/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-30"}},{"id":2573420,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-10T21:44:15.000Z","date":"2021-09-08","kind":"grant","acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025."}],"balance_after":800000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001209191-21-055525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121055525/doc4.xml","form_type":"4"}},{"id":2581976,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-02T22:15:12.000Z","date":"2021-08-31","kind":"purchase","acquired":true,"shares":3830,"price":3.9348,"value":15070.284,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $3.91 to $3.97. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15277948,"source":{"system":"sec-edgar","filing":"0001209191-21-054545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121054545/doc4.xml","form_type":"4"}},{"id":2586773,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-30T23:41:00.000Z","date":"2021-08-30","kind":"purchase","acquired":true,"shares":6000,"price":3.9333,"value":23599.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of prices for the shares of Common Stock is from $3.91 to $3.96. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15274118,"source":{"system":"sec-edgar","filing":"0001209191-21-053958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121053958/doc4.xml","form_type":"4"}},{"id":2586772,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-30T23:41:00.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":6000,"price":3.77,"value":22620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The range of prices for the shares of Common Stock is from $3.74 to $3.83. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15268118,"source":{"system":"sec-edgar","filing":"0001209191-21-053958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121053958/doc4.xml","form_type":"4"}},{"id":2586771,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-30T23:41:00.000Z","date":"2021-08-26","kind":"purchase","acquired":true,"shares":6500,"price":3.8415,"value":24969.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $3.80 to $3.89. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":15262118,"source":{"system":"sec-edgar","filing":"0001209191-21-053958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121053958/doc4.xml","form_type":"4"}},{"id":2626125,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series C Redeemable Preferred Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"exercise","acquired":false,"shares":1071428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Series C Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1071428},"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}},{"id":2626124,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B Redeemable Preferred Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"exercise","acquired":false,"shares":2954285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares received upon the conversion of shares of Series B Redeemable Convertible Preferred Stock. Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of the Series B Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2954285},"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}},{"id":2626123,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Redeemable Preferred Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"exercise","acquired":false,"shares":6316691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the Series A Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares received upon the conversion of shares of Series A Redeemable Convertible Preferred Stock. Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the Series A Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the Series A Redeemable Convertible Preferred Stock automatically converted into one share of the Issuer's Common Stock, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6316691},"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}},{"id":2626122,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"purchase","acquired":true,"shares":627500,"price":8,"value":5020000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share."}],"balance_after":15255618,"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}},{"id":2626121,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"exercise","acquired":true,"shares":1071428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares received upon the conversion of shares of Series C Redeemable Convertible Preferred Stock. All shares were purchased jointly by Hing C. Wong and Bee Yau Huang."}],"balance_after":14628118,"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}},{"id":2626120,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"exercise","acquired":true,"shares":2954285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares received upon the conversion of shares of Series B Redeemable Convertible Preferred Stock. Includes 1,525,714 shares purchased jointly by Hing C. Wong and Bee Yau Huang."}],"balance_after":13556690,"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}},{"id":2626119,"issuer":{"id":8172,"kind":"organization","name":"HCW Biologics Inc."},"owners":[{"id":27519,"kind":"person","name":"Wong Hing C","position":1,"cik":"0001866258","reported_name":"Wong Hing C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-23T23:04:07.000Z","date":"2021-07-22","kind":"exercise","acquired":true,"shares":6316691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares received upon the conversion of shares of Series A Redeemable Convertible Preferred Stock. Includes 902,977 shares purchased jointly by Hing C. Wong and Bee Yau Huang."}],"balance_after":10602405,"source":{"system":"sec-edgar","filing":"0001209191-21-048063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866258/000120919121048063/doc4.xml","form_type":"4"}}]}